Sarcoidosis among hospitalized patients in Poland: a study based on a national hospital registry.

INTRODUCTION Sarcoidosis is a systemic granulomatous disease mainly affecting the lungs, although granulomas can also involve any other organ. OBJECTIVES We sought to describe patients during their first hospitalization for sarcoidosis in Poland from 2008 to 2015. To our knowledge, this is the first evaluation of the disease in Poland based on a hospital morbidity database. PATIENTS AND METHODS We conducted a retrospective, population‑based study, using hospital discharge records compiled by the National Institute of Public Health in the years 2008 to 2015. RESULTS Among the 23 097 patients included in the study, men were predominant (54.7%). The mean and median ages at hospitalization were 44.7 years (95% CI, 44.5-44.9) and 42 years, respectively. Most patients (65%) resided in urban areas. The average annual incidence rate of sarcoidosis was 7.5 per 100 000 (95% CI, 7.1-7.9). The lungs were the most commonly affected organ (57.9%), while the remaining cases included sarcoidosis of lymph nodes and no lung involvement (18%), the skin (1.4%), and other or unspecified sites (22.7%). Skin sarcoidosis occurred significantly more frequently in women, while sarcoidosis of the lungs with coexisting sarcoidosis of lymph nodes was significantly more prevalent in men. Seasonal variability in sarcoidosis incidence was observed. CONCLUSIONS Sex and age may have a significant impact on the occurrence of sarcoidosis in Poland. Changes in seasonality may suggest the role of environmental factors. These data on sarcoidosis in Poland may be helpful in comparative analyses with other European countries.

[1]  K. Roszkowski-Śliż,et al.  Systemic treatment for sarcoidosis was needed for 16% of 1810 Caucasian patients , 2018, The clinical respiratory journal.

[2]  I. Annesi-Maesano,et al.  Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris , 2017, European Respiratory Journal.

[3]  A. White,et al.  Economic burden of sarcoidosis in a commercially-insured population in the United States , 2017, Journal of medical economics.

[4]  F. Bonella,et al.  Epidemiologie und klinisches Erscheinungsbild der Sarkoidose , 2016, Klinische Monatsblätter für Augenheilkunde.

[5]  E. Matteson,et al.  Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota. , 2017, Reumatismo.

[6]  A. Ćmiel,et al.  Endosonography‑guided fine‑needle aspiration in the diagnosis of sarcoidosis: a randomized study. , 2017, Polish archives of internal medicine.

[7]  E. Matteson,et al.  Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976–2013 , 2017, Lung.

[8]  E. Matteson,et al.  Smoking, obesity and risk of sarcoidosis: A population-based nested case-control study. , 2016, Respiratory medicine.

[9]  E. Matteson,et al.  Seasonal variation in incidence of sarcoidosis: a population-based study, 1976–2013 , 2016, Thorax.

[10]  J. Grunewald,et al.  Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden , 2016, European Respiratory Journal.

[11]  M. Brutsche,et al.  In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012 , 2016, PloS one.

[12]  K. Roszkowski-Śliż,et al.  What comorbidities accompany sarcoidosis? A large cohort (n=1779) patients analysis. , 2015, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[13]  P. Kawalec,et al.  The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland , 2015, Expert review of pharmacoeconomics & outcomes research.

[14]  M. Szczyrek,et al.  The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings , 2015, Archives of medical science : AMS.

[15]  P. Spagnolo Sarcoidosis: a Critical Review of History and Milestones , 2015, Clinical Reviews in Allergy & Immunology.

[16]  M. Nørgaard,et al.  Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study , 2014, European Respiratory Journal.

[17]  A. Prasse,et al.  The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. , 2014, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[18]  J. Zejda,et al.  Epidemiology of sarcoidosis recorded in 2006-2010 in the Silesian voivodeship on the basis of routine medical reporting. , 2014, Annals of agricultural and environmental medicine : AAEM.

[19]  P. Polgreen,et al.  An analysis of seasonality of sarcoidosis in the United States veteran population: 2000-2007. , 2012, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[20]  V. Cottin,et al.  Late-Onset Sarcoidosis: A Comparative Study , 2012, Medicine.

[21]  Kira L. Newman,et al.  Occupational causes of sarcoidosis , 2012, Current opinion in allergy and clinical immunology.

[22]  D. Prezant,et al.  Sarcoidosis Diagnosed After September 11, 2001, Among Adults Exposed to the World Trade Center Disaster , 2011, Journal of occupational and environmental medicine.

[23]  Joseph H Abramson,et al.  WINPEPI updated: computer programs for epidemiologists, and their teaching potential , 2011, Epidemiologic perspectives & innovations : EP+I.

[24]  Ragnar Rylander,et al.  Fungal exposure in homes of patients with sarcoidosis - an environmental exposure study , 2011, Environmental health : a global access science source.

[25]  C. Schindler,et al.  Prevalence of sarcoidosis in Switzerland is associated with environmental factors , 2009, European Respiratory Journal.

[26]  M. Olesińska,et al.  Sarcoidosis: selected clinical cases. , 2009, Polskie Archiwum Medycyny Wewnetrznej.

[27]  T. Karayel,et al.  Seasonality of the onset of symptoms, Tuberculin test anergy and Kveim positive reaction in a large cohort of patients with sarcoidosis , 2007, Respirology.

[28]  G. McLennan,et al.  Job and Industry Classifications Associated With Sarcoidosis in a Case–Control Etiologic Study of Sarcoidosis (ACCESS) , 2005, Journal of occupational and environmental medicine.

[29]  G. McLennan,et al.  A case control etiologic study of sarcoidosis: environmental and occupational risk factors. , 2004, American journal of respiratory and critical care medicine.

[30]  J. Tekavec-Trkanjec,et al.  Prevalence of hospitalized patients with sarcoidosis in Croatia. , 2004, Collegium antropologicum.

[31]  M. Yamaguchi,et al.  The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. , 1995, Sarcoidosis.

[32]  R. Baughman,et al.  Predictors of Mortality in Pulmonary Sarcoidosis , 2018, Chest.

[33]  G. Hoser,et al.  Th1/Th2/Th17‑related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis: association with smoking. , 2012, Polskie Archiwum Medycyny Wewnetrznej.

[34]  J. Kozielski,et al.  [Change of patients profile hospitalized because of pulmonary sarcoidosis in Department of Pneumonology in Zabrze (Poland) in 1976-80 and in 1996-2000]. , 2005, Pneumonologia i alergologia polska.

[35]  M. Pérez-Simón,et al.  [Sarcoidosis in a sanitary area at Leon (Spain). Epidemiology and clinical features]. , 2003, Anales de medicina interna.